Search Within

David Hyman

  1. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (25)
Groups
  1. Center for Hematologic Malignancies (53)
  2. Department of Medicine (53)
  3. Early Drug Development Service (53)
  4. Executive Committee, Center for Hematologic Malignancies (53)
  5. Solid Tumor Oncology Division (53)
  6. GSK Faculty (52)

More Groups

People
  1. Eli Diamond (34)
  2. Omar Abdel-Wahab (34)
  3. Jose Baselga (21)
  4. Benjamin Durham (20)
  5. Raajit Rampal (20)
  6. Maria Arcila (19)

More People

Years
  1. 2020 (6)
  2. 2019 (7)
  3. 2018 (8)
  4. 2017 (11)
  5. 2016 (6)
  6. 2015 (8)

More Years

Publications
  1. Blood (16)
  2. Cancer Discovery (6)
  3. Pediatric Blood and Cancer (6)
  4. Journal of Clinical Oncology (3)
  5. Cancer Research (2)
  6. JAMA Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. American Association for Cancer Research (9)
  3. Wiley Periodicals, Inc (6)
  4. American Society of Clinical Oncology (5)
  5. Nature Publishing Group (4)
  6. American Medical Association (3)

More Publishers

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AACR Project GENIE: Powering precision medicine through an international consortium
    Journal Article

    The AACR Project GENIE Consortium
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses
    Meeting Abstract

    Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Mutational analysis of clonal hematopoiesis in solid tumor patients illustrates the critical role of systemic anti-cancer therapies in the evolution of somatic leukemia disease alleles
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; Arcila, M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Vemurafenib in patients with Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH) harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
    Meeting Abstract

    Diamond, E. L.; Subbiah, V.; Lockhart, C.; Blay, J. Y.; Faris, J. E.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J. S.; Erinjeri, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
    Journal Article

    Momtaz, P.; Pentsova, E.; Abdel-Wahab, O.; Diamond, E.; Hyman, D.; Merghoub, T.; You, D.; Gasmi, B.; Viale, A.; Chapman, P. B.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Hatzoglou, V.; Patel, S.; Abdel-Wahab, O.; Rampal, R.; Hyman, D. M.; Holodny, A. I.; Raj, A.
    Orphanet Journal of Rare Diseases (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing of matched normal blood identifies clonal hematopoiesis in a significant subset of solid tumor patients without hematologic malignancies
    Meeting Abstract

    Coombs, C. C.; Zehir, A.; Devlin, S.; Middha, S.; Cheng, D.; Kishtagari, A.; Hyman, D. M.; Solit, D.; Robson, M.; Baselga, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse and targetable kinase alterations drive histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Diamond, E. L.; Haroche, J.; Yao, Z.; Ma, J.; Parikh, S. A.; Choi, J.; Kim, E.; Cohen-Aubart, F.; Lee, S. C. W.; more...
    Blood (2015)

    Fulltext@MSK | Save